Liu et al., hypothesize that increased miR-135b expression promotes tumour progression through targeting the transforming growth factor beta receptor 2 (TGFBR2) [70], which is known to play a key role in cellular processes, including cell cycle regulation, apoptosis, and immune modulation [71]. The gene discussed is TGFBR2; the disease is neoplasm.